Medical Treatment & Prevention

Description

No matching items found.

People

  

  

  

1 of 8

  

  

  

• ALUCK THIPAYARAT
• BOONSERM KAEWKAMNERDPONG
• CHANYAPORN BSTIELER
• DUANGHATHAI WIWATRATANA
• DUJDUAN WARAHO

Publications

  

  

  

3 of 17

  

  

  

• ● Antimicrobial sesquiterpenes from the cultured mycobiont Diorygma pruinosum against methicillin-resistant Staphylococcus aureus isolated from Vietnamese street foods; Thi-Kim-Dung Le, Thuc-Huy Duong, Huy Truong Nguyen, et al.; 2024; Journal article
• ● Antioxidant Activity and Alpha-glucosidase Inhibitory Activity of Traditional Herbal Extracts in the Blood and Body Nourishing Group from upper Northern Regions of Thailand; Premsak Puangploy, Tananya Phansuwan, Ketinun Kittipongpittaya, et al.; 2024; Journal article
• ● A randomized fellow-eye controlled trial study of 1% terpinen-4-ol vs 1% tea tree oil eyelid cleanser for the treatment of meibomian gland dysfunction; Preamjit Saonanon, Wannit Witoonchart, Dusadee Charnvanich, et al.; 2024; Journal article
• ● A SHARED NEURAL MECHANISM UNDERLYING DEFICITS IN SELECTIVE VISUAL ATTENTION ACROSS MILD COGNITIVE IMPAIRMENT SUBTYPES; K. Boonyadhammakul , P. Jetsadapattarakul , M. Hema , et al.; 2024; Poster
• ● A Single-Channel Consumer-Grade EEG Device for Brain-Computer Interface: Enhancing Detection of SSVEP and Its Amplitude Modulation; Autthasan, P; Du, XQ; Arnin, et al.; 2020; Journal article

Projects

  

  

  

1 of 3

  

  

  

• ● Characterizing tissue biomechanical properties for development of artificial tissue; TEERANOOT CHANTHASOPEEPHAN - Department of Mechanical Engineering
• ● Cosmeceutical mask sheet for skin care whitening and antiaging agent using innovative cellulose acetate electrospun fibers doped with a natural oxyresveratal ; NAKORN NIAMNONT - Department of Chemistry
• ● Development of a phototriggerable liposomal delivery system for emblica fruit extract for the treatment of psoriasis; KWANCHANOK PASUWAT - Department of Chemical Engineering
• ● Development of nanobodies specific to the CHRD domain of proprotein convertase subtilisin/kexin type 9 (PCSK9) as biologics for treatment of high blood LDL-cholesterol level; DUJDUAN WARAHO - Faculty of Engineering
• ● Development of nanobody specific to receptor binding domain of SARS-CoV-2 for applying as antibody drug for COVID-19 treatment; DUJDUAN WARAHO - Faculty of Engineering